Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiroyuki Imamichi is active.

Publication


Featured researches published by Hiroyuki Imamichi.


Psychiatry and Clinical Neurosciences | 2001

Long-term outcome in 306 males with alcoholism

Tetsuro Noda; Hiroyuki Imamichi; Akira Kawata; Kenji Hirano; Tatsuo Ando; Yasuo Iwata; Hiroshi Yoneda

Abstract The subjects of this study were 306 male alcoholics who lived in Osaka, Japan, and who were initially diagnosed with alcoholism at a psychiatric institution between 1972 and 1983. Follow‐up studies were done on three occasions: 1 March 1985 (Time 1), 1 November 1988 (Time 2) and 1 March 1992 (Time 3). We followed up 232 (75.8%) of the 306 male alcoholics. By the end of the study period 110 (35.9%) of the subjects were deceased. Regarding cross‐sectional sobriety status, from Time 1 to Time 3 the complete abstinence rate changed from 16.0 to 18.6%, excessive drinking rate was from 13.1 to 9.8%, and controlled drinking rate was from 6.9 to 9.8%. The longitudinal sobriety status of 122 living patients during the 5 years before the close of this study were: rate of stable abstinence, 28.7%; unstable abstinence, 21.3%; controlled drinking, 12.3%; and relapse 37.7%. Such variables as being without public assistance at the time of the initial diagnosis of alcoholism and attending a self‐help group soon after the initial treatment were associated with stable abstinence. Age (20–39 years) and receiving outpatient treatment at the time of the initial treatment also emerged as predictors of survival. However, those variables, except attending a self‐help group soon after the initial treatment, might merely indicate severity of alcoholism. For improving treatment results, it may be most important to provide a treatment environment within the residential area so that alcoholics may receive treatment at an early stage of alcoholism and attend a self‐help group.


Alcohol | 1986

Individual difference in urinary excretion of salsolinol in alcoholic patients

Junko Adachi; Yasuhiko Mizoi; Tatsushige Fukunaga; Yasuhiro Ueno; Hiroyuki Imamichi; Ichiya Ninomiya; Takeaki Naito

Urinary excretion of salsolinol (6,7-dihydroxy-1-methyl-1,2,3,4-tetrahydroisoquinoline) in 30 male alcoholic patients during the withdrawal period was determined. They were divided into two groups, i.e., Group A with 14 subjects had a high level of urinary salsolinol (51.9 +/- 40.8 ng/mg creatinine) on admission to a hospital, and Group B with 16 subjects showed a low level of the substance (3.9 +/- 1.9 ng/mg creatinine). Following a sustained drinking bout, urinary salsolinol in Group A declined to a normal level within a few days. We found that the subjects in Group A showed a greater excretion of urinary dopamine and norepinephrine than those in Group B. There were no differences between the two groups in levels of blood ethanol, serum GOT, GPT and gamma-GTP.


Psychiatry and Clinical Neurosciences | 2001

Cause‐specific mortality risk among male alcoholics residing in the Osaka metropolitan area

Tetsuro Noda; Hiroyuki Imamichi; Hideo Tanaka; Akira Kawata; Kenji Hirano; Tatsuo Ando; Hiroshi Yoneda; Yasuo Iwata; Noriko Kinoshita

Abstract We evaluated the mortality risk among 306 male alcoholics living in Osaka, Japan, at the time of initial diagnosis between 1972 and 1983, with regard to the cause of death, length of time from diagnosis, and participation in an alcohol abstinence self‐help group. By the closing date on 1 March 1992, 110 of the 306 alcoholics had died, yielding an observed‐to‐expected (O/E) ratio of 4.5 [95% confidence interval (CI) = 3.7–5.4]. The alcoholics had significantly elevated mortality risks from all malignant neoplasms (O/E = 2.1, 95%CI = 1.2–3.3), esophageal cancer (O/E = 8.4, 95%CI = 1.7–24.5), diseases of the circulatory system (O/E = 4.4, 95%CI = 3.0–6.2), liver cirrhosis (O/E = 15.9, 95%CI = 10.2–23.6), diseases of the genitourinary system (O/E = 6.3, 95%CI = 1.3–18.5), and external death (O/E = 10.3, 95%CI = 6.3–15.8). The mortality risk from all causes still remained significantly high beyond the tenth year following initial diagnosis (O/E = 2.6, 95%CI = 1.0–6.2). The mortality risks from liver cirrhosis and external death (such as suicide) were highest within the first year following diagnosis, and were still high beyond the tenth year. A significantly high mortality risk from diseases of the circulatory system was observed between the first and ninth years, and the mortality risk from all malignant neoplasms was significantly elevated beyond 10 years following diagnosis. Alcoholics who did not join a self‐help group soon after the initial institutional treatment had different cause‐specific and time‐specific mortality risks from those who did join a self‐help group. These findings show the importance of long‐term clinical follow‐up of male alcoholics, taking into consideration the cause‐specific mortality.


Alcoholism: Clinical and Experimental Research | 1999

Cholesterol Hydroperoxides in Erythrocyte Membranes of Alcoholic Patients

Junko Adachi; Migiwa Asano; Takeaki Naito; Yasuhiro Ueno; Hiroyuki Imamichi; Yoshitsugu Tatsuno

Evidence for the presence of 5α-hydroperoxycholest-6-en-3β-ol (cholesterol 5α-hydroperoxide, Ch 5α-OOH) and 7α- and 7β-hydroperoxycholest-5-en-3β-ols (cholesterol 7-hydroperoxides: Ch 7α-OOH and Ch 7β-OOH, respectively) in human erythrocyte membrane was found. Blood samples were collected from alcoholic patients and healthy volunteers (controls), and their cholesterol hydroperoxides were analyzed by high-performance liquid chromatography postcolumn chemiluminescence and roughly identified by liquid chromatography-mass spectrometry. Ch 7α-OOH and Ch 7β-OOH were present in each sample, being significantly higher in alcoholic samples than in control samples. Ch 5α-OOH was present in some alcoholic samples, but not in the control ones. The accumulation of cholesterol hydroperoxides suggests enhanced lipid peroxidation by active oxygen species and/or a reduced elimination system for lipid peroxide in alcoholic patients.


Alcoholism: Clinical and Experimental Research | 1998

Abnormality of very long-chain fatty acids of erythrocyte membrane in alcoholic patients

Junko Adachi; Atsuko Miwa; Yasuhiro Ueno; Migiwa Asano; Takeaki Naito; Hiroyuki Imamichi; Yoshitsugu Tatsuno

Profiles of very long-chain fatty acids were studied in the erythrocyte membrane of five alcoholic patients. We identified three fatty acids as cis-16-pentacosenoic acid (C25:1), cis-17-hexacosenoic acid (C26:1), and hexacosenoic acid (C26:1), and hexacosanoic acid (C26:0) by gas chromatography-mass spectrometry. The ratios of C26:1/C22:0, C26:0/C22:0, C24:1/C22:0, and C24:0/C22:0 were increased. These findings suggest that active oxygen species or free radicals generated by chronic alcohol consumption in alcohol patients interrupt the peroxisomal beta-oxidation of fatty acids, because very long-chain fatty acids are mainly metabolized by the peroxisomal beta-oxidation system. This is the first study showing accumulation of very long-chain fatty acids in the erythrocyte membrane of alcoholic patients.


Archive | 1985

Induction Factors Related to the Severity of the Alcohol Withdrawal Syndrome

Tatsuo Ando; Kazuhiro Ohishi; Kenji Hirano; Hiroyuki Imamichi; Koji Fujii; Tetsuo Fukuda

M. Victor et al. (1953, 1973) evidenced the time of onset of each withdrawal symptom, and divided the alcohol syndrome into minor and major withdrawal syndromes based on their detailed clinical observations. Subsequently, a good many of the studies on induction factors of the acute withdrawal syndrome have been published; viz., alcohol consumption and drinking period (M. Victor and R.D. Adams, 1953; H. Isbell et al. 1955; K.C. Powell, 1979), drinking pattern (J.H. Mendelson and N.K. Mello, 1970), food intake (J.H. Mendelson, 1970), gastrointestinal symptoms (N.K. Mello, 1972), etc.


Alcoholism: Clinical and Experimental Research | 1996

Effect of the Cytochrome P-1450IIE1 Genotype on Ethanol Elimination Rate in Alcoholics and Control Subjects

Yasuhiro Ueno; Junko Adachi; Hiroyuki Imamichi; Akiyoshi Nishimura; Yoshitsugu Tatsuno


Alcoholism: Clinical and Experimental Research | 1989

Comparative study on ethanol elimination and blood acetaldehyde between alcoholics and control subjects

Junko Adachi; Yasuhiko Mizoi; Tatsushige Fukunaga; Yumi Ogawa; Hiroyuki Imamichi


Alcoholism: Clinical and Experimental Research | 2000

An Association Study Between Alcoholism and the Serotonergic Receptor Genes

Akio Himei; Yoshihiro Kono; Hiroshi Yoneda; Toshiaki Sakai; Jun Koh; Jun Sakai; Yasushi Inada; Hiroyuki Imamichi


Alcoholism: Clinical and Experimental Research | 1996

Identification of Cholesta-3,5-dien-7-one by Gas Chromatography-Mass Spectrometry in the Erythrocyte Membrane of Alcoholic Patients

Junko Adachi; Keiko Hojo; Yasuhiro Ueno; Takeaki Naito; I. Ninomiya; Hiroyuki Imamichi; Yoshitsugu Tatsuno

Collaboration


Dive into the Hiroyuki Imamichi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Takeaki Naito

Kobe Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge